Showing results (391-400 of 432) with videos related to

Sort By:
Pageof 44
Cerebrovascular Diseases (Basel, Switzerland)|January 25, 2008
Reliability and sensitivity of visual scales versus volumetry for evaluating white matter hyperintensity progressionA A Gouw, W M van der Flier, E C W van Straaten, et al.
AJNR. American Journal of Neuroradiology|June 17, 2008
White matter changes contribute to corpus callosum atrophy in the elderly: the LADIS studyC Ryberg, E Rostrup, K Sjöstrand, et al.
Journal of Neurology|September 26, 2006
Simple versus complex assessment of white matter hyperintensities in relation to physical performance and cognition: the LADIS studyA A Gouw, W M Van der Flier, E C W van Straaten, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 23, 2009
White matter hyperintensities and medial temporal lobe atrophy in clinical subtypes of mild cognitive impairment: the DESCRIPA studyL A van de Pol, F Verhey, G B Frisoni, et al.
Alzheimer'S Research & Therapy|February 27, 2021
Characterization of symptoms and determinants of disease burden in dementia with Lewy bodies: DEvELOP design and baseline resultsM van de Beek, I van Steenoven, J J van der Zande, et al.
Neurology|March 12, 2003
The effect of interferon beta-1b on quantities derived from MT MRI in secondary progressive MSM Inglese, J H T M van Waesberghe, M Rovaris, et al.
European Journal of Neurology|August 21, 2012
EFNS task force: the use of neuroimaging in the diagnosis of dementiaM Filippi, F Agosta, F Barkhof, et al.
Multiple Sclerosis and Related Disorders|April 17, 2023
Discontinuation of first-line disease-modifying therapy in relapse onset multiple sclerosisE M E Coerver, A Bourass, M H J Wessels, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 13, 2009
Location of lacunar infarcts correlates with cognition in a sample of non-disabled subjects with age-related white-matter changes: the LADIS studyS Benisty, A A Gouw, R Porcher, et al.
Journal of Neurology|February 1, 2023
Temporal evolution of new T1-weighted hypo-intense lesions and central brain atrophy in patients with a first clinical demyelinating event treated with subcutaneous interferon β-1aH Vrenken, M Battaglini, M L de Vos, et al.
Pageof 44